YCharOS (Antibody Characterization through Open Science)

YCharOS (Antibody Characterization through Open Science)

NeuroDisorder Development (NDD) - Autism

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
Home Gateways YCharOS (Antibody Characterization through Open Science)
1-4 of 4 ARTICLES
 in 
https://doi.org/10.12688/f1000research.160174.1
Data Note metrics
A guide to selecting high-performing antibodies for STXBP1 (UniProt ID: P61764) for use in western blot, immunoprecipitation, and immunofluorescence
[version 1; peer review: 1 approved]
Riham Ayoubi, Charles Alende, Maryam Fotouhi, Sara González Bolívar, Carl Laflamme, NeuroSGC/YCharOS/EDDU collaborative group, ABIF consortium
Peer Reviewers Lynne Howells
  • Funders
  • Simons Foundation Autism Research Initiative
  • Québec Consortium for Drug Discovery
PUBLISHED 24 Dec 2024
https://doi.org/10.12688/f1000research.160121.1
Data Note metrics
A guide to selecting high-performing antibodies for ADNP (UniProt ID: Q9H2P0) for use in western blot, immunoprecipitation, and immunofluorescence
[version 1; peer review: 2 approved, 1 approved with reservations]
Vera Ruíz Moleón, Charles Alende, Maryam Fotouhi, Riham Ayoubi, Sara González Bolívar, Carl Laflamme, NeuroSGC/YCharOS/EDDU collaborative group, ABIF consortium
Peer Reviewers Richard O'Kennedy; Christian Peter Moritz; Illana Gozes, Maram Ganaiem and Artur Galushkin
  • Funders
  • Simons Foundation Autism Research Initiative
  • Mitacs
  • Genome Canada, Genome Quebec and Ontario Genomics
PUBLISHED 20 Dec 2024
https://doi.org/10.12688/f1000research.153243.2
Data Note metrics
Revised
A guide to selecting high-performing antibodies for CSNK2A1 (UniProt ID: P68400) for use in western blot, immunoprecipitation and immunofluorescence
[version 2; peer review: 1 approved, 2 approved with reservations]
Riham Ayoubi, Maryam Fotouhi, Charles Alende, Vera Ruíz Moleón, Kathleen Southern, Carl Laflamme, NeuroSGC/YCharOS/EDDU collaborative group, ABIF consortium
Peer Reviewers Odile Filhol and Catherine Pillet; David Litchfield; Miwako Homma
  • Funders
  • Ontario Genomics
  • from Canadian Institutes of Health Research Foundation
  • Simons Foundation Autism Research Initiative
  • Mitacs
  • Genome Quebec
  • Genome Canada
LATEST VERSION PUBLISHED 05 Sep 2024
https://doi.org/10.12688/f1000research.145146.2
Data Note metrics
Revised
A guide to selecting high-performing antibodies for Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PPP2R5D) for use in Western Blot, immunoprecipitation and immunofluorescence
[version 2; peer review: 2 approved]
Riham Ayoubi, Maryam Fotouhi, Charles Alende, Kathleen Southern, Carl Laflamme, NeuroSGC/YCharOS/EDDU collaborative group, ABIF consortium
Peer Reviewers Nadia Bouhamdani; Dario Siniscalco and Mauro Finicelli
  • Funders
  • Ontario Genomics
  • Simons Foundation Autism Research Initiative
  • Canadian Institutes of Health Research Foundation
  • Mitacs
  • Genome Quebec
  • Genome Canada
LATEST VERSION PUBLISHED 09 Jul 2024
1-4 of 4 ARTICLES
Gateway Areas
  • Amyotrophic Lateral Sclerosis (ALS)
    This gateway area serves as a comprehensive resource, filtering the antibody characterization articles for ALS-associated proteins nominated by the Amyotrophic Lateral Sclerosis Reproducible Antibody Platform (ALS-RAP) as well as relevant analyses and research regarding ALS and the ALS-RAP initiative.
      Read more keyboard_arrow_right
  • Alzheimer's Disease (AD)
    This gateway area functions as a complete guide to filter the antibody characterization articles for AD-associated proteins nominated by the TarGet Enablement to Accelerate Therapy Development for AD (TREAT-AD) Center or the Accelerated Medicines Partnership for AD (AMP-AD). It also provides valuable research findings pertaining to AD as well as the analysis of YCharOS’s progress in the context of the targets nominated by these two initiatives. Read more keyboard_arrow_right
  • Parkinson's disease (PD)
    This gateway area presents the antibody characterization data for protein targets nominated by the Michael J. Fox Foundation for Parkinson's Research. Read more keyboard_arrow_right
  • Rab GTPase Family
    This area serves to filter the articles providing antibody characterization data for Rab proteins, a family of over 60 small GTPases, regulating vesicle trafficking processes. Read more keyboard_arrow_right
  • NeuroDisorder Development (NDD) - Autism
    This section highlights articles featuring antibody characterization data for protein targets related to neurodevelopmental disorders (NDD) and autism. The research in this area is partially funded by the Simons Foundation Autism Research Initiative (SFARI).
      Read more keyboard_arrow_right
Our News
  • YCharOS Consensus Protocols Now Available in Nature Protocols launch

    This collaborative paper, co-authored by representatives from 11 leading antibody manufacturers and knockout cell line providers, details the YCharOS antibody characterization protocols. These protocols outline the use of knockout cell lines to evaluate antibody performance in western blotting, immunoprecipitation, and immunofluorescence. Additionally, the paper offers practical tips and best practices for antibody users.

  • YCharOS highlighted in Nature Protocols News and Views launch

    The YCharOS Consensus Protocols are further spotlighted in a Nature Protocols News and Views article by Monteiro, Voskuil, and Williams, which highlights the YCharOS platform and other complementary efforts in advancing antibody characterization.

  • YCharOS in Nature launch

    The News Feature published in Nature explores a range of initiatives aimed at tackling the antibody reliability problem. The piece spotlights YCharOS as a leading effort in this field, detailing its origins, achievements to date, and future goals.

  • Antibody Specificity: A strong case for third-party testing launch

    Article summarizing the findings from Ayoubi et al,eLife, 2023 that emphasized the extensive use of non-specific antibodies in research and presented a compelling case for third-party antibody testing.

  • Antibody characterization is critical to enhance reproducibility in biomedical research launch

    Overview of the history of the antibody characterization crisis, efforts to address the problem and actions stakeholders can take in order to increase reproducibility of research which rely on antibodies

  • YCharOS in Protocol Exchange launch

    A consensus platform for antibody characterization

  • YCharOS in eLife launch

    Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications

Our Links
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.